Kimberly Kaneshige

发表

Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants

B. Poindexter, M. Walsh, E. Eichenwald, 2021, Clinical Pharmacokinetics.

Effects of percutaneous aortic valve replacement on coronary blood flow assessed with transesophageal Doppler echocardiography in patients with severe aortic stenosis.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Effect of insurance type on adverse cardiac events after percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2011, American Journal of Cardiology.

Insurance type influences the use of drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, JACC. Cardiovascular interventions.

Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, Journal of interventional cardiology.

Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three‐vessel coronary artery disease

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Incidence, predictors, and outcome of new, subsequent lesions treated with percutaneous coronary intervention in patients presenting with myocardial infarction.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2008, The American journal of cardiology.

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty.

K. Kent, A. Pichard, L. Satler, 2009, Cardiovascular revascularization medicine : including molecular interventions.

Outcomes in diabetic versus nondiabetic patients who present with acute myocardial infarction and are treated with drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

The predictive value of computed tomography calcium scores: a comparison with quantitative volumetric intravascular ultrasound.

N. Weissman, G. Mintz, K. Kent, 2008, Cardiovascular revascularization medicine : including molecular interventions.

Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents

K. Kent, A. Pichard, L. Satler, 2008 .

Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The clinical significance of hematocrit values before and after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, American heart journal.

Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacement.

G. Lemesle, K. Kent, A. Pichard, 2010, The American journal of cardiology.

Response to Letters Regarding Article, “Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?”

G. Lemesle, K. Kent, A. Pichard, 2011 .

Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Outcomes in patients with intra-aortic balloon pump who met the same inclusion criteria in the PROTECT II (a prospective feasibility trial investigating the use of the impella recover LP 2.5 system in patients undergoing high risk percutaneous coronary intervention) Study

G. Lemesle, K. Kent, A. Pichard, 2009 .

Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?

G. Lemesle, K. Kent, A. Pichard, 2010, Cardiovascular revascularization medicine : including molecular interventions.

Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents.

K. Kent, A. Pichard, L. Satler, 2010, American heart journal.

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.

K. Kent, A. Pichard, L. Satler, 2009, American Journal of Cardiology.

Abstract 4542: Does Proton Pump Inhibitor Use Following Percutaneous Coronary Intervention With Drug-eluting Stents Impact Clinical Outcome?

K. Kent, A. Pichard, L. Satler, 2009 .

Insurance Type Inﬂuences the Use of Drug-Eluting Stents

A. Pichard, L. Satler, S. Collins, 2022 .

Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

CORONARY ARTERY DISEASE Impact of Bivalirudin Use on Outcomes in Nonagenarians Undergoing Percutaneous Coronary Intervention

G. Lemesle, K. Kent, A. Pichard, 2009 .

The impact of live case transmission on patient outcomes during transcatheter aortic valve replacement: results from the VERITAS study.

J. Webb, A. Colombo, R. Torguson, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial).

T. Ryan, R. Torguson, R. Waksman, 2012, The American journal of cardiology.

Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).

T. Ryan, L. Räber, A. Kirtane, 2014, JACC. Cardiovascular interventions.

Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling

Karan R. Kumar, M. Laughon, G. Kearns, 2021, Clinical Pharmacokinetics.

Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.

G. Lemesle, K. Kent, A. Pichard, 2009, Archives of cardiovascular diseases.

Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions.

G. Lemesle, K. Kent, A. Pichard, 2008, The American journal of cardiology.

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.

N. Weissman, K. Kent, A. Pichard, 2008, European heart journal.

Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device?

K. Kent, A. Pichard, L. Satler, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2010, The American journal of cardiology.

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?

G. Lemesle, K. Kent, A. Pichard, 2010, Circulation.

Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).

K. Kent, A. Pichard, L. Satler, 2010, The American journal of cardiology.

Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period.

K. Kent, A. Pichard, L. Satler, 2008, The American journal of cardiology.

Vascular brachytherapy for patients with drug-eluting stent restenosis.

G. Lemesle, A. Pichard, L. Satler, 2008, Journal of interventional cardiology.

Erratum to “Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?" (Cardiovasc Revasc Med 2010;11(2):91–7)

G. Lemesle, K. Kent, A. Pichard, 2011 .

Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Population characteristics, treatment assignment, and clinical outcome of patients with severe aortic stenosis who were not eligible to participate in a clinical trial evaluation percutaneous aortic valve replacement

K. Kent, A. Pichard, L. Satler, 2009 .

Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.

Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention

G. Lemesle, K. Kent, A. Pichard, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Abstract 4456: The Impact of Nuisance Bleeding on Clopidogrel Compliance in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

K. Kent, A. Pichard, L. Satler, 2008 .

Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.

K. Kent, A. Pichard, L. Satler, 2009, The American journal of cardiology.

Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.

G. Lemesle, K. Kent, A. Pichard, 2009, The American journal of cardiology.